Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical therapy for ulcerative colitis.

Niraj Jani1, Miguel D Regueiro

  • 1Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.

Gastroenterology Clinics of North America
|July 19, 2002
PubMed
Summary

Aminosalicylates and corticosteroids are key treatments for ulcerative colitis (UC). For non-responsive patients, cyclosporine offers a significant advance, while other agents show potential alternative therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.

Gastroenterology·2025
Same author

Safety Outcomes in Patients With Ulcerative Colitis Using a Healthcare Administrative Database in the United States.

Inflammatory bowel diseases·2025
Same author

Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases.

Inflammatory bowel diseases·2023
Same author

Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial.

Alimentary pharmacology & therapeutics·2022
Same author

Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2021
Same author

Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.

Journal of clinical gastroenterology·2021

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Aminosalicylates and corticosteroids are standard treatments for ulcerative colitis (UC).
  • Patients unresponsive or dependent on steroids require alternative therapies like immunomodulators or surgery.
  • Cyclosporine is a significant recent advancement in UC treatment.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for ulcerative colitis (UC).
  • To highlight the role of cyclosporine as a major treatment advance.
  • To explore the potential of alternative agents for refractory UC cases.

Main Methods:

  • Review of existing literature on ulcerative colitis (UC) treatments.
  • Analysis of the efficacy and role of various therapeutic agents.
  • Categorization of treatments based on response and patient profiles.

Main Results:

  • Aminosalicylates and corticosteroids remain the primary treatments for UC.
  • Cyclosporine represents a major therapeutic advancement for UC.
  • The roles of nicotine, heparin, antibiotics, probiotics, and short-chain fatty acids (SCFA) in UC treatment require further investigation but may offer alternatives.

Conclusions:

  • Standard therapies for UC include aminosalicylates and corticosteroids.
  • Cyclosporine is a key treatment option for patients not responding to standard therapy.
  • Alternative agents warrant further study for patients with UC intolerant or nonresponsive to conventional treatments.

Related Experiment Videos